{"id":"W3210639163","doi":"10.1136/ijgc-2021-esgo.641","title":"58 KEYNOTE-826: Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pembrolizumab; Medicine; Bevacizumab; Chemotherapy; Carboplatin; Internal medicine; Placebo; Oncology; Cervical cancer; Clinical endpoint; Surgery; Cancer; Randomized controlled trial; Cisplatin; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001045569,0.0008706246,0.002169452,0.0004341259,0.0003275721,0.0009076638,0.0008012635,0.001389469,0.02438562],"category_scores_gemma":[0.001677404,0.0004083891,0.001708733,0.0003113193,0.0004882286,0.001014634,0.0004123735,0.003659123,0.002090278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006819125,"about_ca_system_score_gemma":0.000842064,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009083435,"about_ca_topic_score_gemma":0.001945651,"domain_scores_codex":[0.9995364,0.0002082428,0.0000416258,0.00007813962,0.00004585808,0.00008978372],"domain_scores_gemma":[0.9994717,0.0002218112,0.00009117787,0.0000283,0.00003025868,0.0001567526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9359243,0.003641603,0.0002530354,0.001530244,0.0009707428,0.00004521765,0.00003451679,0.0004910621,0.004868521,0.000330153,0.004198589,0.04771201],"study_design_scores_gemma":[0.7931045,0.1853989,0.005225239,0.0003342793,0.002200336,0.0001169379,0.00008078389,0.001161412,0.002580814,0.0007341594,0.009016073,0.00004657291],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9213733,0.02686335,0.001484233,0.004162907,0.008108201,0.006191461,0.00694826,0.000379775,0.02448851],"genre_scores_gemma":[0.9609737,0.007461308,0.002211221,0.002681367,0.001499157,0.003868318,0.002389,0.00005586055,0.01885999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02438562,"threshold_uncertainty_score":0.08157808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.073051747860394,"score_gpt":0.3840308324736213,"score_spread":0.3109790846132273,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}